Andrea Ferreira-Gonzalez, PhD
Professor of Pathology; Chair of Molecular Diagnostics Division
Phone: (804) 828-9564
Fax: (804) 825-4738
Andrea Ferreira-Gonzalez, PhD, was appointed Chair of the Division of Molecular Diagnostics in the Department of Pathology at the Virginia Commonwealth University Health System in July 2008. She has also been the director of the Molecular Diagnostics Laboratory at the VCU Health Systems since 1994. Dr. Ferreira-Gonzalez received her PhD degree from the George Washington University in Washington DC in 1994, Argentina and she is board certified by the American Board of Bioanalysis as High Complexity Laboratory Director and Clinical Consultant.
Dr. Ferreira-Gonzalez is an internationally recognized expert in the field of molecular diagnostics in the area of genetics, oncology, precision medicine and infectious diseases in transplantation In addition; Dr. Ferreira-Gonzalez has played a major role in shaping national policy regarding the practice, reimbursement and guideline development for molecular diagnostics and molecular genetic testing. Her publication record demonstrates well over 100 publications in peer-reviewed literature and chapters. She is sought both nationally and internationally in the scientific, health management and business development communities as an accomplished leading authority.
At the national level, Dr. Ferreira-Gonzalez is a consultant for the US Health and Human Services Department for the FDA’s Clinical Genetics Panel of the Medical Devices Advisory Committee, Center for Devices and Radiological Health. She also serves in the Genomic Medicine Advisory Committee for the US Department of Veterans Administration. Dr Ferreira-Gonzalez served as a member of the Secretary of Health and Human Services Advisory Committee on Genetics, Health and Society (SACGHS) where she was the Chair of the SACGHS Task Force on Genetic Testing Oversight and on the Personalized Healthcare Workgroup. She also served as a member of the Clinical Laboratory Improvement Advisory Committee (CLIAC) to Health and Human Services. She has been involved in the development of clinical guidelines with the Clinical and Laboratory Standards Institute and the Association for Molecular Pathology (AMP). Dr. Ferreira-Gonzalez has also served as President of the Association for Molecular Pathology and Chair of the Professional Relations Committee and Secretary/Treasurer for the same organization. She was the chair of the nominating Committee for the American Association of Clinical Chemistry and chair for the Capital section for the same association. More recently, Dr. Ferreira-Gonzalez served on the Department of Justice and National Institute of Standard and Technology National Commission on Forensic Sciences. Dr. Ferreira-Gonzalez was the recipient of the AMP Leadership Award for her major contributions to the field. At the international level, Dr. Ferreira-Gonzalez is a member of the Molecular Biology Education Committee for the International Federation of Clinical Chemistry (IFCC) where she has participated over the last 6 years in developing educational standards and hands on workshops on genetic testing for developing countries.
Dr. Ferreira-Gonzalez is interested in clinical translation research and the clinical implementation of new nucleic acid based technology for patient care. This is reflected in her research and publications relating to new technology such as Next Generation Sequencing for different clinical applications. Dr. Ferreira-Gonzalez has been a PI on several industry sponsored clinical trials for different clinical applications of devices. A number of these clinical trials resulted in FDA approval of those devices.
Dr. Ferreira-Gonzalez has a passion for molecular diagnostics education and has had an active role in the Department, Medical Center, and as an invited lecturer/course director at both national and international meetings such as College of American Pathologists, American College of Medical Genetics, Association for Molecular Pathology, American Society of Clinical Pathology, American Association for Clinical Chemistry and International Federation of Clinical Chemistry.
Clinical Specialties: Development and Application of Nucleic Acid Probe Technology to Diagnosis and Monitoring of Human Diseases